Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Basal Cell Carcinoma Chemoprevention Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating basal cell carcinoma chemoprevention is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Basal Cell Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING